Development
Cardlytics, Inc.
CDLX
$1.79
$0.116.55%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 89.17M | 79.01M | 76.70M | 64.33M | 82.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 89.17M | 79.01M | 76.70M | 64.33M | 82.50M |
| Cost of Revenue | 49.68M | 43.16M | 46.19M | 39.81M | 49.19M |
| Gross Profit | 39.49M | 35.85M | 30.52M | 24.52M | 33.31M |
| SG&A Expenses | 28.01M | 29.72M | 31.48M | 27.02M | 37.29M |
| Depreciation & Amortization | 6.70M | 5.99M | 7.20M | 6.58M | 6.85M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.90M | 91.30M | 99.71M | 84.97M | 108.03M |
| Operating Income | -7.73M | -12.29M | -23.01M | -20.63M | -25.53M |
| Income Before Tax | -100.84M | -23.97M | -23.51M | 13.61M | -378.28M |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -100.84M | -23.97M | -23.51M | 13.61M | -378.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.84M | -23.97M | -23.51M | 13.61M | -378.28M |
| EBIT | -7.73M | -12.29M | -23.01M | -20.63M | -25.53M |
| EBITDA | -1.04M | -6.30M | -15.81M | -14.06M | -18.68M |
| EPS Basic | -2.56 | -0.63 | -0.67 | 0.41 | -11.32 |
| Normalized Basic EPS | -0.09 | -0.26 | -0.40 | -0.36 | -0.40 |
| EPS Diluted | -2.56 | -0.63 | -0.67 | 0.40 | -11.32 |
| Normalized Diluted EPS | -0.09 | -0.26 | -0.40 | -0.33 | -0.40 |
| Average Basic Shares Outstanding | 39.45M | 37.98M | 34.88M | 33.60M | 33.42M |
| Average Diluted Shares Outstanding | 39.45M | 37.98M | 34.88M | 36.73M | 33.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |